Euglycaemic diabetic ketoacidosis in a 43-year-old woman with type 2 diabetes mellitus on SGLT-2 inhibitor (empagliflozin)

Drug Ther Bull. 2021 Jun;59(6):93-95. doi: 10.1136/dtb.2021.235117rep. Epub 2021 Jan 28.

Authors

Azka Latif^{1

2}, Aheli Arce Gastelum¹, Akshat Sood¹, Joseph Thilumala Reddy³

Affiliations

¹ Internal Medicine, CHI Health Creighton University Medical Center Bergan Mercy, Omaha, Nebraska, USA.
² CHI Creighton Health, Creighton University Medical Center-University Campus, Omaha, Nebraska, USA.
³ Internal Medicine, CHI Health Creighton University Medical Center Bergan Mercy, Omaha, Nebraska, USA docjoe111@yahoo.com.

PMID: 33509834
DOI: 10.1136/dtb.2021.235117rep

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Diabetes Mellitus, Type 2 / drug therapy*
Diabetic Ketoacidosis / chemically induced*
Female
Humans
Sodium-Glucose Transporter 2 Inhibitors / adverse effects*
Sodium-Glucose Transporter 2 Inhibitors / therapeutic use

Substances

Sodium-Glucose Transporter 2 Inhibitors